Another study illustrated that HS6ST2 was highly expressed in papillary thyroid cancer, thyroid cancer, and high-grade cartilage tumor tissues12, though it was expressed at low levels in glioma tissues13, and HS6ST2 was also found to promote the development of thyroid cancer14,15. Here, HS6ST2 is linked to central nervous system cancer.